You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
加科思-B(01167.HK)委任高級副總裁周文來博士為首席生物學家
格隆匯 04-30 22:35

格隆匯 4 月 30日丨加科思-B(01167.HK)宣佈,董事胡邵京博士因其他職業追求原因將於2021年5月12日起不再擔任公司研發總裁一職,胡邵京博士仍為公司執行董事。

公司研發計劃並不受胡邵京博士卸任研發總裁而有所影響。董事長兼首席執行官王印祥博士將繼續領導公司的研發工作。於過去一年,共有四位副總裁及高級副總裁加入集團,有效增強了集團從全球臨牀開發、專利保護、數據庫建立等全方位的能力。

公司高級副總裁周文來博士將被委任公司首席生物學家一職,同時兼任高級副總裁一職,自公吿日期起即日生效。

周文來博士自2016年加入公司起,擔任高級副總裁,負責藥物發現、生物學和轉化醫學等相關工作。周文來博士擁有20年以上的科研及工業界經驗,曾擔任美國諾華生物醫學研究中心腫瘤事業部實驗室主任及研究員。周文來博士擁有澳大利亞墨爾本大學分子生物學博士學位,並在美國加州大學聖地亞哥分校醫學院完成博士後研究。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account